Mercer Island, WA, United States of America

Sen-itiroh Hakomori


 

Average Co-Inventor Count = 3.0

ph-index = 11

Forward Citations = 412(Granted Patents)


Location History:

  • King County, WA (US) (1991)
  • Mercer Island, WA (US) (1989 - 2012)

Company Filing History:


Years Active: 1989-2012

Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Innovative Contributions of Sen-itiroh Hakomori in Glycosphingolipid Research

Introduction

Sen-itiroh Hakomori, based in Mercer Island, WA, is a prolific inventor with a significant portfolio of 25 patents. His research primarily focuses on glycosphingolipids and their implications in medical treatments, specifically concerning bacterial infections.

Latest Patents

Among his latest inventions are the patents titled "Anti-extended type I glycosphingolipid antibody, derivatives thereof and use" and "Compositions for treating Escherichia coli urinary tract infections." The former covers human antibodies and antigen-binding portions that specifically target extended Type I chain glycosphingolipids. The latter provides methods for diagnosing, treating, and preventing recurrent urinary tract infections through the detection and use of globosides, including disialosyl galactosyl-globoside (DSGG) and sialosyl galactosyl-globoside (SGG).

Career Highlights

Sen-itiroh Hakomori has held prominent positions at renowned research institutions such as The Biomembrane Institute and Fred Hutchinson Cancer Research Center. His work in these organizations has significantly advanced the understanding of glycosphingolipids and their medical applications.

Collaborations

Throughout his career, Hakomori has collaborated with various esteemed scientists, including Edward D. Nudelman and Yasuyuki Igarashi. These partnerships have enhanced the depth of his research and led to substantial contributions in the field.

Conclusion

Sen-itiroh Hakomori's innovative efforts in the realm of glycosphingolipids have the potential to reshape medical practices related to urinary tract infections. His extensive patent portfolio and collaborations with other experts highlight his impactful role in advancing biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…